GlobeImmune (GBIM) Files $69M IPO

July 2, 2012 5:33 PM EDT
Get Alerts GBIM Hot Sheet
Trade GBIM Now!
Join SI Premium – FREE
GlobeImmune, Inc. (Nasdaq: GBIM) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $69 million. GlobeImmune applied to list on the Nasdaq Global Market under the ticker, "GBIM."

The offering is being made through Wells Fargo Securities, Piper Jaffray, and JMP Securities.

GlobeImmune is a biopharmaceutical company focused on developing therapeutic products for cancer and infectious diseases based on our proprietary Tarmogen platform.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Piper Jaffray, JMP Securities, Wells Fargo

Add Your Comment